Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-157,722
Closed -$10.6M 144
2025
Q3
$10.6M Sell
157,722
-5,721
-4% -$380K 0.54% 79
2025
Q2
$10.6M Sell
163,443
-3,172
-2% -$190K 0.57% 71
2025
Q1
$10.3M Buy
166,615
+28,240
+20% +$1.87M 0.55% 81
2024
Q4
$9.98M Sell
138,375
-4,020
-3% -$314K 0.5% 91
2024
Q3
$11.6M Sell
142,395
-16,903
-11% -$1.35M 0.54% 80
2024
Q2
$11.8M Sell
159,298
-7,223
-4% -$541K 0.54% 88
2024
Q1
$13M Buy
166,521
+87,999
+112% +$6.55M 0.57% 84
2023
Q4
$5.61M Buy
+78,522
New +$5.47M 0.26% 138

Other funds holding HOLX

Leeward Investments's HOLX Position: Q4 2025 in Review

Leeward Investments sold out of Hologic (HOLX) in Q4 2025, closing a stake of 157,722 shares — an estimated $10.6M sold.

Leeward Investments first reported a position in HOLX in Q4 2023 and held it in 8 quarters. The position peaked at $13M in Q1 2024. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Leeward Investments reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Leeward Investments sold 157,722 Hologic shares in Q4 2025, an estimated $10.6M.
  • Leeward Investments first reported a position in Hologic in Q4 2023 and held it in 8 quarters.
  • Leeward Investments's Hologic position peaked at $13M in Q1 2024.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Leeward Investments's 13F filing for Q4 2025, filed 5 Feb 2026.